MegJardine AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia

MegJardine
Professor Meg Jardine is the Director of the NHMRC Clinical Trials Centre, the University of Sydney and Lead of the Kidney Health Research Program. Her research has focussed on investigating the progression and complications of non-communicable diseases, particularly kidney disease and diabetes. She has experience in the design and conduct of national and international trials. Prof Jardine has a particular interest in expanding the use of innovative and cost-effective methodologies to increase the generation of high-quality evidence. Her interests include the integration of clinical care and research endeavours, and the promotion of learning health system principles to contribute to their efficient delivery. Prof Jardine is a member of the Executive Committees of the International Society of Nephrology (ISN) and a past Board member of KDIGO. She is Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) initiative. She serves as a Board Member of the Kidney Health Initiative, a public-private collaboration of the American Society of Nephrology and the US (United States) FDA (Food and Drug Administration). She is a Board member of the Australian Clinical Trials Alliance (ACTA) and a member of the ANZSN (Australia and New Zealand Society of Nephrology) Research Advisory Committee. Prof Jardine is a specialist nephrologist at Concord Repatriation General Hospital and a proud recipient of the Australian and New Zealand Society of Nephrology T.J.Neale award for Outstanding Contribution to Nephrological Science.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/27150d786950eae434ada6acdcb5d391.jpg
First Name
Meg
Last Name
Jardine
Institution
Country.
Australia

Friday, February 7, 2025

Time Session
2:15 p.m.
3:45 p.m.
IK2001
LilyMushahar Chair MalaysiaLily Mushahar, Hospital Tuanku Ja'afar Seremban, Malaysia
SudarshanBallal Chair IndiaNephrologist and Chairman, Manipal Hospitals, India, Bengaluru
  • How Do I…Set Up and Implement Multidisciplinary Kidney Care?
    IK2001-03
    IfeomaUlasi Speaker NigeriaCollege of Medicine, University of Nigeria
  • How Do I…Manage Kidney Transplant Recipients Who Are Losing Their Graft?
    IK2001-02
    SunitaBavanandan Speaker MalaysiaHospital Kuala Lumpur, Malaysia
  • How Do I…Get Pregnant With Kidney Disease?
    IK2001-01
    SilviShah Speaker United StatesUniversity of Cincinnati, Ohio, United States
  • How Do I…Conduct Immune Risk Stratification of Potential Kidney Transplant Recipients?
    IK2001-04
    AjayKher Speaker IndiaEpitome Kidney Urology Institute And Lions Hospital, Delhi
  • How Do I…Design and Implement Large Simple Trials?
    IK2001-05
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Q&A
    IK2001-06
Parijat Hall 201

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
SS2
AdeeraLevin Chair CanadaUniversity of British Columbia and Providence Health Care
AndreaViecelli Chair AustraliaUniversity of Queensland
Ajit singhNarula Chair India
  • Novel Trial Designs in Nephrology: Innovations and Structures
    SS2-01
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • What’s New in Clinical Trials?
    SS2-02
    DavidWheeler Speaker United KingdomUniversity College London
  • Value of Different Outcomes in the Era of Precision Medicine
    SS2-03
    RobertoPecoits Filho Speaker United StatesArbor Research Collaborative for Health
  • Conducting Trials in Low and Middle-income Countries
    SS2-04
    SoumitaBagchi Speaker IndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi
  • Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct
    SS2-05
    ArpanaIyengar Speaker IndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE
  • Q&A
    SS2-06
Parijat Hall 201
4:15 p.m.
5:15 p.m.
BKH1002
BrianPereira Chair United States
GhadaAnkawi Chair Saudi ArabiaKing Abdulaziz University
MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Addressing Challenges: Early CKD Detection Strategies and the Role of Research and Development in Global Kidney Health
    BKH1002-01
    AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care
  • A Collaborative Approach to Detecting Kidney Disease Early
    BKH1002-02
    ThomasBlakeman Speaker United KingdomThe University of Manchester
  • Harnessing Digital Technology: Innovative Tools for Early CKD Detection and Management
    BKH1002-03
    Chinta RamaKrishna Speaker IndiaChinta Rama Krishna, Vedanta Hospitals
  • Q and A
    BKH1002-04
Kesar Hall 202

Sunday, February 9, 2025

Time Session
11 a.m.
12 p.m.
HIT3
DilushiWijayaratne Chair Sri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka
JAIPRAKASHTIWARI Chair IndiaProfessor and Head, Department of Nephrology, Goa Medical College, Goa, India ;MD, DM Nephrology, FISN, FISOT
  • Findings and Lessons from the PARADIGM Research Consensus Conference
    HIT3-1
    AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care
  • Findings and Lessons from ALIGN Study Design
    HIT3-2
    HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES
  • Findings and Lessons from RESOLVE Study Design
    HIT3-3
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Findings and Lessons from LIFT Study
    HIT3-4
    DebasishBanerjee Oral Abstract Presenter United KingdomSt George's University Hospital NHS Foundation Tr
  • Q and A
Brahmkamal Hall - Plenary Hall
12:15 p.m.
1:15 p.m.
PL4
MarcelloTonelli Chair CanadaUniversity of Calgary
MasaomiNangaku Chair Japan
MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Diabetes and Adipocytokines. Brenner/Dirks Lecture
    PL4-1
    TakashiKadowaki Speaker JapanToranomon Hospital
  • Message from Outgoing ISN President
    PL4-2
    MasaomiNangaku Chair Japan
  • Message from Incoming ISN President
    PL4-4
    MarcelloTonelli Chair CanadaUniversity of Calgary
Brahmkamal Hall - Plenary Hall

Thursday, February 6, 2025

Time Session
2:45 p.m.
4:05 p.m.
SHARE RR2
MegJardine Chair AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia
  • Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia
    SHARE RR2-001
    RachaelMorton Speaker AustraliaNHMRC Clinical Trials Centre, The University of Sydney
  • Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data
    SHARE RR2-002
    Juan-JesusCarrero Speaker SwedenKarolinska Institutet
  • Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK
    SHARE RR2-003
    FergusCaskey Speaker United KingdomUniversity of Bristol, UK
  • Q and A
    SHARE RR2-004
Kesar Hall 202